LIG3 and neoplasm: In addition, some recent studies demonstrated that mutations in DNA repair genes are associated with improved OS in ICI-treated patients, regardless of the tumor mutation burden.32, 33, 34 As it is widely believed that genetic mutations might trigger AAb production,35 this could be one possible explanation for the presence of anti-LIG3 AAbs in our patients and their association with favorable clinical outcomes.